Company profile: KGK Science
1.1 - Company Overview
Company description
- Provider of customized clinical trials, virtual trials (Participant Reported Outcomes and Customized Virtual Trials), preclinical studies, and regulatory consulting for the nutraceutical, cannabis, hemp, psychedelic, dietary supplement, functional food, beverage, ingredient, and cosmetic industries, supporting product development, claim substantiation, and regulatory submissions.
Products and services
- Expert Regulatory Services: KGK supplies regulatory support services for nutraceutical, cannabis, hemp, and psychedelic industries, helping clients navigate regulatory requirements and pathways for product development and claims substantiation
- Innovative Virtual Trials: KGK delivers virtual trials, including Participant Reported Outcomes Virtual Trials (PRO-VTâ„¢) and Customized Virtual Trials (C-VTâ„¢), enabling remote, cost-effective research across health and wellness studies
- Premium Clinical Trials: KGK architects and conducts customized clinical trials for product development and claim substantiation across nutraceutical, cannabis, hemp, and psychedelic sectors, leveraging 21 years of experience to support claims
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to KGK Science
Nordic Bioscience
HQ: Denmark
Website
- Description: Provider of ECM-focused biomarker technologies and services for precision drug development, including Protein Fingerprint technology to quantify extracellular matrix fragments in blood, laboratory biomarker analysis for clinical trials, the PRO-C3 biomarker for type III collagen formation, and the GRIPonMASH platform for early MASH detection and management with AI-based decision support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nordic Bioscience company profile →
Percuro
HQ: Brazil
Website
- Description: Provider of clinical research and health services, committed to the provision of effective treatments in a safe and supportive environment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Percuro company profile →
Tergus Pharma
HQ: United States
Website
- Description: Provider of end-to-end topical pharmaceutical research, drug development, testing, and manufacturing services as a CDMO, including contract R&D and commercial manufacturing for topical pharmaceuticals, plus cGMP-compliant testing services. Based in Durham, North Carolina.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tergus Pharma company profile →
Equalis
HQ: Sweden
Website
- Description: Provider of external quality assessment services for medical and diagnostic laboratories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Equalis company profile →
Gentronix
HQ: United Kingdom
Website
- Description: Provider of regulatory genotoxicity studies (GLP Ames, mouse lymphoma, in vitro micronucleus), predictive genotoxicity screening to detect liability early, skin toxicology assays for corrosion, irritation and sensitisation, and flow cytometry services. Includes Ames MPF/II and 24-well Agar formats requiring low test item amounts. Supports drug development and chemicals in cosmetics, personal care, and other chemistry driven industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gentronix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for KGK Science
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to KGK Science
2.2 - Growth funds investing in similar companies to KGK Science
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for KGK Science
4.2 - Public trading comparable groups for KGK Science
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →